BRCA1 and central nervous system cancer: The mean BRCA1 positivity was increased in WHO grade II gliomas (mean=5.92%) compared with NB (P=0.5344, n.s., One-way ANOVA and Tukey’s multiple comparisons test; Fig. 6a,b).